Aggregate Safety Assessment Planning

ASAP

method for collecting and evaluating safety data throughout drug development that evolves over a product’s life-cycle and promotes interdisciplinary, systematic safety planning as well as ongoing data review and characterization of the emerging product safety profile. Objectives include alignment on the safety topics of interest, identification of safety knowledge gaps, planning for aggregate safety evaluation of the clinical trial data and preparing for safety communications.

Course: REG209